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resistance in plant cells, plant seeds, plant tissues and plants 
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broad-spectrum pathogen resistance in plant cells, plant 
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USE OF HRMA PROTEINS AND THEIR 
GENES FOR BROAD RANGE PROTECTION 
OF PLANTS AGAINST BACTERIAL, 
FUNGAL AND VIRAL PATHOGENS 
This Work Was supported in part by a grant from the 
Tobacco and Health Research Institute, University of Ken 
tucky. 
TECHNICAL FIELD 
The present invention generally relates to the use of 
HrmA proteins to elicit a hypersensitive response in plant 
cells, plant seeds, plant tissues and plants. The present 
invention also relates to the use of pathogen inducible or any 
promoters With the hrmA gene to express the HrmA proteins 
in plant cells, plant seeds, plant tissues and plants. 
BACKGROUND ART 
Plants are capable of combating disease at several levels. 
In many instances, defense responses are initiated by a 
speci?c gene-for-gene interaction, Whereby the product of a 
particular plant defense gene interacts With a corresponding 
pathogen gene product (elicitor), thereby triggering a series 
of cellular events that culminate in a localiZed cell-death 
response (or hypersensitive response; Dangl et al., 1996; 
Gilchrist, 1998) and enhanced resistance in unchallenged 
parts of the plant (SAR; Ryals et al., 1996). The plant gene 
products involved in gene-for-gene defense mechanisms are 
typically receptor-like molecules, and the initial interactions 
of these putative receptors With their ligands (of pathogen 
origin) is thought to trigger a sophisticated series of signal 
ing events (Bent, 1996; Baker et al., 1997). Among the 
consequences are increased local production of active oxy 
gen species, accelerated local cell death, induction of sali 
cylic acid and jasmonic acid synthesis, and production, in 
unchallenged parts of the plant, of a battery of proteins and 
metabolites that have been associated With enhanced sys 
temic resistance to a broad range of pathogens (Dangl et al., 
1996). 
The properties of plants that are induced for SAR are 
attractive from the perspective of pathogen resistance: they 
are usually protected against a broad range of bacterial, 
fungal, and viral pathogens, yet they may display little or no 
harmful effects otherWise (e.g., serious yield losses, aberrant 
developmental patterns, etc.). As mentioned in the preceding 
paragraph, challenge With so-called incompatible pathogens, 
Which necessarily leads to a hypersensitive response, 
induces SAR (Sticher et al., 1997). Challenge With non 
pathogenic microbes can also induce SAR (Van Loon et al., 
1998). Certain chemicals may be able to induce SAR in 
treated plants (Gorlach et al., 1996; Morris et al., 1998; Rao 
and Davis, 1999). The expression of any of a number of 
genes that, While not of pathogenic origin per se, can induce 
hypersensitive responses or cause disease-like lesions, can 
trigger SAR, apparently through a means similar to that by 
Which incompatible pathogens induce SAR (Dangl et al., 
1996). 
In light of the range of stimuli knoWn to induce SAR, 
several strategies have been tested to genetically engineer 
plants so that they are constitutive for SAR, or can be 
induced With agents not usually associated With disease and 
defense responses. Expression of both plant resistance and 
microbial avr genes in the same plant has been tested; When 
the avr gene is controlled by a promoter Whose activity is 
induced upon challenge by pathogens (including those unre 
lated to the source of the avr gene), the resulting plants can 
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2 
respond to so-called compatible pathogens as if possessing 
a speci?c gene-for-gene system (Hammond-Kosack et al., 
1994; 1998). Constitutive expression of genes Whose prod 
ucts act doWnstream from the putative receptors can result in 
constitutive SAR (Oldroyd and StaskaWicZ, 1998). 
Interestingly, in some instances, the resulting plants dis 
played feW (if any) detrimental side effects, indicating that 
it is possible to condition permanent SAR Without seriously 
affecting plant groWth and development, or crop yield 
(BoWling et al., 1997; Yu et al., 1998; Oldroyd and 
StaskaWicZ, 1998). Induced or constitutive expression of 
microbial avr gene, elicitor or elicitor-like genes and other 
so-called disease lesion-mimic genes can also induce SAR 
constitutively in plants (Dangl et al., 1996). 
The hypersensitive response of higher plants is charac 
teriZed by the rapid, localiZed death of plant cells at the site 
of pathogen invasion. It occurs during incompatible 
interactions, Which typically involve a microorganism that 
causes disease only in another plant, and is associated With 
resistance against many nematodes, fungi, viruses, and 
bacteria. When HR is induced by a genetically engineered 
avr gene expressed under the control of a loW-level expres 
sion promoter or other controlled expression promoters, the 
responses of the plant are subtle and, most likely, at a 
microscopic scale. 
The avr genes from the species Pseudomonas syringae are 
suitable for the purpose of obtaining genetically engineered 
SAR. Different strains cause symptoms ranging from galls to 
“Wild?re” blights, and Well-characterized virulence 
(symptom enhancing) factors are as diverse as phytohor 
mones and peptide toxins. Multiple patterns of host speci 
?city (including, in some cases, avirulence (avr)-mediated 
gene-for-gene interactions) involve virtually all crop plants, 
and plant associations vary from epephytism to devastating 
pathogenesis. The interactions With diversi?ed plant spe 
cises imply the possibility that avr genes may cause HR in 
many different plants. 
It is noW knoWn that that elicitation of the HR by R 
syringae requires a bacterium that is able to synthesiZe an 
Avr protein and to directly inject the Avr protein into the 
doomed plant cell. (See He, 1998, Ann. Rev. Phytopathol., 
36:363—392). The ability of Pseudomonas syringae strains 
to elicit the HR or pathogenesis in nonhost or host plants, 
respectively, is controlled by the hrp genes, and typical Hrp 
mutants have the null phenotype of a nonpathogen in all 
plants. [See Proc. Nat’l. Acad. Sci. USA, 82:406 (1985); J. 
BaterioL, 168:512 (1986); and Mol. Plant—]\/Iicr0be 
Interact, 4:132 (1991)]. Hrp genes are clustered, and some 
appear to be Widely conserved in Gram-negative bacterial 
pathogens that cause eventual necrosis in their hosts. These 
pathogens include Pseudomonas syringae, Pseudomonas 
solancearum, Xanthomonas campestris, Erwinia 
amylovora, Erwinia stewartii, and Erwinia chrysanthemi. 
[See Mal. Plant—Micr0be Interact, 5:390 (1992)]. The hrp 
clusters from Pseudomonas syringae pv. syringae 61 (Which 
has been deposited With the American Type Culture Collec 
tion under the provisions of the Budapest Treaty and Which 
is designated as AT CC 55427) encode for proteins that 
assemble the type III secretion system to deliver Avr protein 
into plant cells. Through genetic engineering, the avr gene 
can be expressed inside the plant cell, thus by passing the 
delivery system that is required in native bacterial system. 
As a result, the avr genes from R syringae can thus be used 
to obtain even broad range protection in plants. 
The present inventors have discovered that it is desirable 
to express a broad-spectrum avr gene that can elicit resis 
tance response in many cultivars and plant species so that the 
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same avr expression construct can be used to generate 
resistance in multiple plants and cultivars. Many avr genes 
are identi?ed initially based on their ability to trigger the HR 
and resistance in one or a feW cultivars of a given plant 
species (Leach and White, 1996). However, further exami 
nation of the avirulence effect of these avr genes on other 
plant species often uncovers additional plant species and 
cultivars that react With an HR to these avr genes. To date, 
more than 50 pathogen avr genes (most from bacteria) have 
been cloned and characteriZed. These avr genes provide a 
useful resource for genetic engineering of broad-spectrum 
resistance in many crop plants. The hrmA gene is a broad 
spectrum avr gene; it has been shoWn to trigger an HR in all 
examined tobacco cultivars (Alfano et al., 1997) and trans 
formed Arabidopsis thaliana (Q. Li and S. Shen, unpub 
lished observation). The present inventors have also discov 
ered that a pathogen-inducible plant promoter With a very 
loW basal level of expression (estimated in betWeen 
10_7—10_4 of poly(A) RNA) can alloW this strategy to Work. 
The present inventors have demonstrated the use of the 
A0.3TobRB7 promoter sequence to express the highly 
potent HR elicitor gene, hrmA. HoWever, a large collection 
of pathogen-infection-speci?c promoters can be used to 
make the inducible expression, or loW-level non-inducible 
expression promoters can be used to make constitutive 
expression, of avr genes more versatile in different plants, 
tissues, and/or developmental stages. The expression of the 
avr genes, in particular example of this patent hrmA, Would 
induce SAR thus Warrant a neW methods to genetically 
engineer SAR in crops. 
SUMMARY OF THE INVENTION 
The invention provides a method of increasing resistance 
of plants to pathogens that involves introducing avr genes 
into plants and expressing avr proteins. 
The invention thus provides novel chimeric gene con 
structs that contain avr coding sequences. 
The invention also provides transformed plant cells, plant 
seeds, plant tissues and transgenic plants transformed With 
novel chimeric gene constructs that contain the avr coding 
sequences. 
The invention thus provides a method for the expression 
of the avr genes in plant cells, plant seeds, plant tissues and 
plants. 
The invention also provides the use of pathogen inducible 
promoters, or any promoter to express the avr genes in plant 
cells, plant seeds, plant tissues and plants. 
According to an embodiment of the invention, a bacterial 
HR elicitor, hrmA of R syringae and homologeus thereof, 
are expressed in plants such as tobacco under the control of 
a promoter, such as A0.3TobRB7, Which is expressed in 
loW-level constitutively. A forced expression of the HR in 
otherWise susceptible plants leads to increased resistance to 
pathogen infection. 
Additional advantages of the present invention Will be set 
forth in the description and examples that folloW, or may be 
learned from practicing the invention. These and other 
advantages may be realiZed and attained by means of the 
features, instrumentalities and/or combinations particularly 
described herein. It is also to be understood that the fore 
going general description and the folloWing detailed descrip 
tion are only exemplary and explanatory and are not to be 
vieWed as limiting or restricting the invention as claimed. 
The invention itself, together With further advantages, Will 
best be understood by reference to the folloWing detailed 
description taken in conjunction With the accompanying 
draWings. 
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BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1. A schematic representation of hrmA-T-DNA con 
structs in the binary vector pKYLX7.1. The positions of the 
T-DNA left border (TL), double 35S promoter (35S2), 
A0.3TobRB7 promoter (A0.3Tob), the Pr-1b signal peptide 
genes (SP), hrmA gene, and the 3‘ UTR (from pea rbcS gene) 
are illustrated. Not shoWn next to the right side of the 
construct is the NPTII gene (for Kanamycin resistance) 
expression cassette and the T-DNA right border. 
FIG. 2. Appearance of transgenic plants carrying the TSA 
construct. (A) Comparison of T1 plants derived from the 
TSA-2 and TSA-30 primary transformants With a trans 
formed control. (B) Close-up of an older leaf from a TSA-2 
plant shoWing the necrosis that occasionally appears. The 
arroWs point to some examples of the necrosis spots. 
FIG. 3. Expression of the hrmA gene in the TSA-2 and 
TSA-30 transgenic lines. hrmA or [3-tubulin transcripts Were 
ampli?ed by RT-PCR as described in Methods. hrmA band 
Were detected by Southern blotting using hrmA-speci?c 
radioactive probe. The DNA products corresponding to 
ampli?cation products of the [3-tubulin gene Were visualiZed 
by ethidium bromide staining. PCR Without prior reverse 
transcription Was used as control to con?rm that the RT/PCR 
products Were attributable to RNA. Lanes containing the 
products of RT/PCR and PCR are denoted above the gels. 
For comparison, RNA isolated from the transformed control 
Was also analyZed. 
FIG. 4. Expression of pathogenesis-related genes in 
TSA-2 and TSA-30 plants. Total RNA Was isolated from 
kanamycin-resistant T1 progeny of the TSA-2 and TSA-30 
plants or from transformed control plants. 20 pg of total 
RNA Was analyzed by northern blotting, using tobacco pr1 
and pr2-speci?c probes as described in Methods. The 
ethidium bromide-stained 18S rRNA is shoWn as a loading 
control. 
FIG. 5. Levels of free (A) and total (B) salicylic acid in 
control and hrmA transgenic plants. Transformed control 
and kanamycin resistant T1 progeny of the TSA-2 and 
TSA-30 plants Were sampled and SA determined as 
described in Methods. SA for each line Was determined in 
triplicate. 
FIG. 6. Resistance of hrmA transgenic plants to viral 
pathogens. (A) Appearance of inoculated leaves of controls 
and representative TSA-2 plants, shoWing the HR-like 
necrosis that is characteristic of the TSA plants. The pho 
tograph Was taken one day after inoculation With the indi 
cated virus. (B) Comparison of an upper (systemic) leaf 
from a TVMV-inoculated control and a TSA-30 plant, 
shoWing the characteristic TVMV symptoms on the control, 
and lack thereof on the TSA-30 plant. (C) Immunoblot 
determination of TVMV and TEV coat protein levels in 
plants inoculated With TVMV and TEV. Samples Were taken 
tWo Weeks after inoculation. 
FIG. 7. Resistance of hrmA transgenic plants to Wild ?re 
disease caused by R syringe pv. tabaci WF4. (A) GroWth of 
R syringae pv. tabaci on inoculated TSA-2 or control plants. 
The data represent the mean of three replicate experiments; 
standard deviations for each point are shoWn as Well. (B) 
Lesions caused by in?ltration With different dilutions of R 
syringae pv. tabaci bacteria suspensions. An original sus 
pension With an OD (600 nm) of 1.0 Was diluted 1,000 times 
(spot 1), 5,000 times (spot 2), and 10,000 times (spot 3). 
Spot 4 is a buffer control. 
FIGS. 8(A)—8(C). Resistance of hrmA transgenic plants to 
the fungal pathogen Phytophthora parasitica var. nicotianae 
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isolate 62. TSA-2 and TSA-30 plants Were compared With a 
transformed control, as described in Methods. 
DETAILED DESCRIPTION OF THE 
INVENTION 
SEQ ID NO. 1 is the nucleotide sequence of Pseudomo 
nas syringae pv. syringae 61 hrmA gene (from Heu et al., 
Which discloses the nucleotide sequence for the hrmA locus 
associated With the Pseudomonas syringae pv. syringae 61 
hrp cluster and the characteriZation of the physical and 
phenotypic properties of the gene product). The deduced 
amino acid sequence is shoWn by SEQ ID NO. 2. 
Recognition of pathogen avirulence (Avr) factors by plant 
resistance gene products triggers disease resistance response 
in plants. The hrmA gene from Pseudomonas syringae pv. 
syringae has previously been shoWn to confer avirulence on 
the virulent bacterium R syringae pv. tabaci in all examined 
tobacco cultivars. Basal level expression of the hrmA gene 
in tobacco plants under the control of the tobacco 
A0.3TobRB7 promoter activates the expression of 
pathogenesis-related genes, accumulation of salicylic acid, 
and the transgenic plants exhibit high levels of resistance to 
multiple leaf pathogens: tobacco vein mottling virus, 
tobacco etch virus, black shank fungus Phytophthora 
parasitica, and Wild ?re bacterium Pseudomonas syringae 
pv. tabaci. Thus, controlled loW level expression of bacterial 
avr genes, such as hrmA, can be used in plants to generate 
broad-spectrum resistance to bacterial, fungal and viral 
pathogens. 
During host-pathogen co-evolution, many plants have 
acquired disease resistance genes Whose products are 
involved directly or indirectly in the recognition of 
pathogen-derived molecules called avirulence factors 
(StaskaWicZ et al, 1995). Recognition of pathogen aviru 
lence factors by the plant resistance gene products results in 
activation of plant disease resistance responses, including 
often a localiZed plant cell death response knoWn as the 
hypersensitive response (HR) (Goodman and Novacky, 
1994; Dangl et al., 1996; Lamb and Dixon, 1997). In plant 
pathogenic bacteria, the function of avr genes is dependent 
on hypersensitive response and pathogenicity (hrp) genes 
(beach and White, 1996). Many hrp genes are involved in 
regulation and assembly of a type III protein secretion 
system (He, 1998). GroWing indirect evidence suggests that 
bacterial Avr proteins are delivered directly into the plant 
cell via the Hrp system (He, 1998; Collmer, 1998; Bonas and 
Van den Ackerveken, 1999). For example, the hrmA gene of 
Pseudomonas syringae pv. syringae confers broad-spectrum 
avirulence on R syringae pv. tabaci in all examined suscep 
tible host tobacco (Alfano et al., 1997). The avirulence 
function of the hrmA gene is dependent on hrp genes (Heu 
and Hutcheson, 1993; Alfano et al., 1997). Puri?ed HrmA 
protein does not trigger the HR When in?ltrated into the 
apoplast of tobacco leaves; hoWever, transient expression of 
the hrmA gene directly in tobacco cells results in cell death, 
suggesting recognition of HrmA inside the tobacco cell 
(Alfano et al., 1997). 
Constitutive high-level expression of an avr gene in 
resistant plants results in a systemic HR and the transgenic 
plants die, as Was observed for transgenic expression of the 
R syringae pv. glycinea avrB gene in the resistant Arabi 
dopsis thaliana ecotype Columbia (Gopalan et al., 1996). 
The present inventors have discovered, hoWever, that con 
trolled expression of avr genes at very loW levels or in 
response to virulent pathogen infection may be used to 
generate plant disease resistance Without causing signi?cant 
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and constitutive damage to uninfected plant tissues. The 
tobacco A0.3TobRB7 promoter sequence Was previously 
shoWn to be induced speci?cally at the feeding site of 
root-knot nematodes (Opperman et al., 1994). The basal 
level expression of this promoter sequence Was apparently 
very loW and Was undetectable based on [3-glucuronidase 
activity assay in transgenic tobacco plants. The very loW 
level of basal expression (estimated level betWeen 
10_7—10_4 of poly(A) RNA) and induction by nematode 
infection make the A0.3TobRB7 promoter sequence an 
excellent candidate for testing the feasibility of loW level 
and conditional expression of avr genes for generating 
disease resistant plants. The basal level of hrmA expression 
may trigger expression of systemic acquired resistance 
against pathogens thus preventing further disease develop 
ment. 
Experimental Results 
Production and Characterization of hrmA-Transgenic 
Tobacco Plants 
The Pseudomonas syringae hrmA gene is modi?ed for 
expression in plants as shoWn in FIG. 1. Several different 
variations are tried, as indicated. TWo constructs consist of 
the hrmA gene under the control of the modi?ed 35S 
promoter present in pKYLX71135S2 (Maiti et al., 1993). 
One of these includes the pathogenesis related protein signal 
peptide (Cornelissen et al., 1986) suited for targeting of the 
predicted gene product to the endomembrane system (and 
presumably to the apoplast). These constructs are termed 
35A and 35SA, respectively (FIG. 1). In tWo other 
constructs, the modi?ed 35S promoter Was replaced With the 
A0.3TobRB7 promoter (Opperman et al., 1994). This pro 
moter has been reported not to express Without the challenge 
of roots With root-knot nematodes. One of the A0.3TobRB7 
constructs (TA) consists of just the promoter ?anked by the 
hrmA gene, Which is expected to express the HrmA protein 
intracellularly. A second construct (TSA) contains a PR-1b 
signal peptide (SP) at the N-terminus of the hrmA coding 
region. 
An attempt to introduce the 35A and 35SA chimeric genes 
into plants using Agrobacterium tumefaciens Was unsucces 
ful. When leaf explants are treated With Agrobacteria car 
rying the 35A or the 35SA construct, no transgenic callus 
Was obtained. This is consistent With the previous ?nding by 
Alfano et al. (1997) that high level expression of the HrmA 
protein leads to hypersensitive cell death in tobacco cells. Of 
special interest is the observation that inclusion of the signal 
peptide does not permit the isolation of transformants. 
No transgenic plants Were obtained With Agrobacteria 
carrying the TA construct, suggesting that the basal level of 
intracellular hrmA expression under the control of 
A0.3TobRB7 Was still detrimental to plant groWth or devel 
opment. This result is someWhat surprising, because the 
A0.3TobRB7 promoter Was reported to be active only in 
giant nurse cells formed in roots as a consequence of 
invasion by nematodes (Opperman et al., 1994). HoWever, 
Agrobacteria that carry the TSA construct yield a small 
number of viable transformant lines, possibally due to the 
signal peptide that leads the HrmA protein to be secreted 
outside the cell membrane Where HrmA may not function as 
an Avr factor (as found by Alfano et al., 1997). Thus, the 
signal peptide reduces hrmA concentration inside the cell by 
mediating the translocation of neWly synthesiZed protein 
outside the cell membrane. Southern blot analysis con?rms 
that these plants carry the transgene (data not shoWn). The 
six independent TSA lines can be classi?ed into 3 types: 1) 
plants displaying normal groWth, 2) plants displaying severe 
stunting and necrosis (not shoWn), and 3) plants displaying 
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minor alterations in growth (lines 2 and 30, FIG. 2A). Line 
2 shoWs a near-normal groWth With slightly rigid leaves and 
With some micro-lesions on older leaves (FIG. 2B). Line 30 
shoWs a modest retardation of root system development. 
HoWever, once roots are established, TSA-30 is indistin 
guishable from control plants (FIG. 2A), and lacks the 
micro-lesions that typify the plants from line 2. 
The altered groWth habit of transgenic plants is indepen 
dent of any challenge by nematodes, suggesting that the 
A0.3TobRB7 promoter ret ains a loW level of activity in the 
absence of nematode infection. To con?rm this, the expres 
sion level of the hrmA gene in all transgenic lines Was 
examined. The present inventors found that hrmA mRNA 
cannot be detected in any of the transgenic plants by 
northern analysis, presumably due to loW levels of expres 
sion (not shoWn). HoWever, reverse transcription 
polymerase chain reaction (RT-PCR) combined With South 
ern blot analysis is effective in detecting the hrmA mRNA in 
transgenic leaves and roots; thus hrmA is expressed consti 
tutively in these plants (FIG. 3), but at loW levels beloW the 
detection of northern blot analysis. The apparent hrmA 
expression level is much higher in the TSA-2 line than in the 
TSA-30 line, Which is consistent With the appearance of 
micro lesions in TSA-2, but not in TSA-30. 
Expression of Pathogenesis-related Genes 
The appearance of micro lesions on old leaves of TSA-2 
and delayed root development in TSA-30 suggest that loW 
level constitutive expression of the hrmA gene in these 
plants leads to induction of hypersensitive and systemic 
defense responses. To con?rm this, the levels of expression 
of tWo pathogenesis-inducible genes in vector-transformed 
control plants and in TSA-2 and TSA-30 plants are mea 
sured. When RNA from leaves of TSA-2 and TSA-30 plants 
is hybridiZed With probes of PR-1a and PR-2 (encoding 
[3-1,3-glucanase), constitutive expression of these genes is 
observed in the TSA lines, but not in the control plants (FIG. 
4). Moreover, there is a positive correlation betWeen the 
levels of expression of these tWo genes in the TSA lines 
(FIG. 4) and the quantities of hrmA RT-PCR product that are 
observed (FIG. 3). Thus, it appears that hrmA gene 
expression, even at very loW levels, is suf?cient for the 
induction of defense responses. 
In Wild-type plants, the induction of the pathogen related 
PR-1 and PR-2 genes by incompatible pathogens is medi 
ated by salicylic acid, the synthesis of Which is dramatically 
increased as a consequence of the activation of defense 
responses. The induced expression of PR-1 and -2, salicylic 
acid, are the indicators of SAR (see Sticher, et al., Systemic 
acquired resistance, Ann. Rev. Phytopathol, 35, 235—270 
(1997). To better understand the means by Which hrmA 
expression induces PR-1 and PR-2 expression, the levels of 
salicylic acid in the TSA-2 and TSA-30 plants is compared 
With the levels in control plants. As shoWn in FIG. 5, the 
levels of free and total salicylic acid in the TSA plants are 
greater than those seen in controls. This is especially true for 
the TSA-2 plants, Which also have the highest levels of PR 
gene (FIG. 4) and hrmA (FIG. 3) expression. These obser 
vations demonstrate that loW-level hrmA expression induces 
local and systemic defense responses in the TSA plants. 
Resistance to Virulent Pathogens 
The constitutive expression of the PR-1 and PR-2 genes 
in leaves of the TSA-2 and TSA-30 lines (FIG. 4), and the 
elevated levels of salicylic acid and its conjugates in the TSA 
plants (FIG. 5), suggest that these lines exhibit enhanced 
resistance to various pathogens. This is examined by study 
ing the responses of these lines to tWo viruses (tobacco vein 
mottling virus [TVMV] and tobacco etch virus [TEV]), a 
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bacterial pathogen, Pseudomonas syringae pv. tabaci, and a 
fungal pathogen, Phytophthora parasitica. 
TWo differences betWeen the TSA lines and the control 
line are observed When plants of each line are inoculated 
With either of the tWo viruses. Within one day of inoculation, 
the TSA lines exhibit HR-like necrosis on the leaves that had 
been inoculated With TVMV or TEV (FIG. 6A). The HR 
necrosis is restricted to the inoculated leaf tissue (FIG. 6A). 
This necrotic response is characteristic of just the TSA 
plants. In numerous previous inoculation studies With 
TVMV and TEV (Xu et al., 1997 and 1998; Fellers et al., 
1998; Maiti et al., 1993), such effects have never been 
observed With other tobacco lines, transgenic or otherWise. 
Beginning about ?ve days post-inoculation, typical vein 
mottling or leaf etch symptoms are invariably detected on 
the uninoculated upper leaves of control plants that had been 
infected With TVMV (FIG. 6B) or TEV. In contrast, the 
uninoculated upper leaves of infected TSA-2 or TSA-30 
plants remain free of disease symptoms (FIG. 6B). 
Moreover, virus accumulation, as judged by the presence of 
virus coat protein, could not be detected in the TSA-2 or 
TSA-30 plants (FIG. 6C). In contrast, considerable coat 
protein is detected in the upper leaves of infected control 
plants (FIGS. 6C). These results demonstrate that, after the 
initial hypersensitive reaction to infection that is seen in the 
inoculated leaf, the TSAplants are Wholly resistant to further 
systemic spread of TVMV and TEV. 
To study the susceptibility of the TSA lines to bacterial 
diseases, experiments are performed With Pseudomonas 
syringe pv. tabaci, the Wild ?re disease pathogen. After 
inoculation of control plants, the bacterial population at the 
inoculation site is found to increase in a linear fashion over 
the course of three days (FIG. 7A), and characteristic 
symptoms (spreading necrosis and chlorosis) are apparent at 
these sites (FIG. 7B, left panel). In contrast, no bacterial 
groWth is seen in inoculated TSA-2 plants, and symptoms 
indicative of disease are conspicuously absent on inoculated 
TSA-2 (FIG. 7B, right panel) and TSA-30 (FIG. 7B, middle 
panel) plants. TSA plants exhibit a HR-like necrosis at the 
site of inoculation; this necrotic response is also observed 
When plants are mock-inoculated. 
To study the susceptibility of the TSA lines to fungal 
diseases, TSA and control plants are inoculated With plugs of 
media containing Phytophthora parasitica var. nicotianae 
isolate 62, the black shank disease pathogen. Four days after 
inoculation of a control plant leaf, a necrotic area With a 20 
mm diameter is apparent, indicative of successful infection 
by this pathogen (FIG. 8). In contrast, cell death is restricted 
to the leaf tissue that Was touched by the pathogen plug in 
leaves from TSA-30 and TSA-2 plants, indicative of a local 
hypersensitive response (FIG. 8). Moreover, these leaves are 
devoid of the fungus (not shoWn). Thus, the TSA plants 
display resistance to R parasitica, again consistent With the 
constitutive expression of PR genes and resistance to the 
viral and bacterial pathogens tested. 
In summary, loW level expression of a bacterial HR 
elicitor may thus be used as a means for controlling disease. 
LoW-level constitutive expression of the hrmA gene yields 
plants that possess high levels of resistance against a broad 
range of microbial plant pathogens Without signi?cantly 
affecting normal plant groWth and development. 
Speci?cally, transgenic lines 2 and 30 exhibit near-normal 
groWth and are highly resistant to TVMV, TEV, P. s. pv. 
tabaci, and R parasitica. The most dramatic response of 
hrmA transgenic plants to pathogen inoculation is an 
HR-like necrosis at the site of pathogen inoculation, irre 
spective of Whether or not inoculated pathogens normally 
US 6,342,654 B1 
induce necrosis in tobacco. For example, TVMV and TEV 
normally cause systemic vein mottling and leaf etch, but not 
necrosis in tobacco; the hrmA transgenic plants, in contrast, 
respond to virus inoculation With a rapid, localized HR-like 
necrosis, and the viruses are unable to spread beyond the 
inoculated sites. A similar necrotic response is observed 
When the hrmA transgenic plants are inoculated With bac 
terial and fungal pathogens. The mechanism by Which this 
response is triggered remains unclear. One possibility is that 
pathogen infection increases the expression of hrmA gene at 
the inoculation site. The increased hrmA expression Would 
then activate a higher level of defense responses, including 
the appearance of a macroscopic HR. Alternatively, a loW 
level of hrmA gene expression in the transgenic plants may 
partially activate defense mechanisms, including the HR cell 
death program. Consistent With this prediction, hrmA plants 
constitutively express PR genes, elevated salicylic acid 
level, and in TSA-2 plants, micro HR-like lesions are present 
in old leaves. These transgenic plants are noW hypersensitive 
to certain environmental stresses, e.g., infection by virulent 
pathogens, that alone normally are not suf?cient to activate 
the HR cell death program and other defense responses. 
In several respects, the hrmA transgenic line TSA-30 
shoWs hallmarks of the Arabidopsis thaliana cpr (for con 
stitutive PR gene expression) class of mutants that consti 
tutively express defense genes and exhibit heightened resis 
tance to pathogen infection (Clarke et al., 1998). TSA-2, on 
the other hand, exhibits some features of the ‘lesion mimic’ 
class of mutants of maiZe, barley, tomato, and Arabidopsis 
thaliana (Neuffer and Calvert, 1975; Hoisington et al., 1982; 
Walbot et al., 1983; Wolter et al., 1993; Dietrich et al., 1994; 
Greenberg et al., 1994; BoWling et al, 1994 and 1997). In 
‘lesion mimic’ mutants, HR-like lesions and host defense 
mechanisms are activated in the absence of a pathogen. The 
cpr and ‘lesion mimic’ classes of mutants as Well as the 
hrmA transgenic plants are effective in containing pathogen 
infection. 
Alfano et al. (1997) shoWed that intracellular expression 
of the hrmA gene triggers HR cell death in tobacco, Whereas 
in?ltration of puri?ed HrmA protein to the apoplast of 
tobacco leaves does not. It Was therefore suggested that 
HrmA acts inside the plant cell to trigger HR. The present 
experiments did not generate transgenic tobacco plants that 
produce the HrmA protein intracellularly. HoWever, a num 
ber of transgenic plants that presumably express the HrmA 
protein extracellularly Were generated, but the number Was 
unexpectedly small. The difficulty in producing transgenic 
plants that express HrmA extracellularly Was unexpected, 
given that HrmA does not appear to elicit HR from outside 
of the tobacco cell. A likely explanation is that the transport 
of the pre-HrmA polypeptide is someWhat less than 100% 
ef?cient; this, along With a loW level of constitutive activity 
of the A0.3TobRB7 promoter, Would result in levels of 
intracellular HrmA high enough to kill many transformed 
cells. 
An additional surprising ?nding Was the loW-level activity 
of the A0.3TobRB7 promoter in the hrmAplants. Aprevious 
study (Opperman et al., 1994) indicated that this promoter 
Was active only in giant cells, With undetectable levels of 
expression in other cells. The present experiments shoW that 
the A0.3TobRB7 promoter is active at levels beneath the 
sensitivity of the GUS reporter system, but detectable by 
more sensitive methods (such as RT/PCR). This constitutive 
expression is apparently the reason Why plants designed to 
express intracellular HrmA could not be produced. 
HoWever, We need to point out that the A0.3TobRB7 is not 
necessarily required for the succuss of the loW expression of 
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hrmA gene. In theory, any promoter conferring that level 
expression, or other stronger promotes regulated to express 
in loW levels may also lead to the right level expression of 
hrmA or other similar avr genes. 
Experimental Methods 
DNA Manipulations 
Recombinant DNA manipulations are performed basi 
cally as described by Sambrook et al. (1989). Tobacco 
(Nicotiana tabacum cv. Wisconsin 38) genomic DNA is used 
as template for ampli?cation of the A0.3TobRB7 promoter 
(Yamamoto et al., 1991 and Opperman et al., 1994). Oligo 
nucleotide A0.3TobRB7—5‘ (G 
GAATTCAGCTTATCTAAACAAAGTTTTAAATTC) 
(SEQ ID NO.6) and A0.3TobRB7—3‘ (GT 
AAGCTTCTGAGCGNFCCTTCTCACTAGAAAAKFGCCC) 
(SEQ ID NO. 7) are used in polymerase chain reaction 
(PCR). The PCR product is then digested With EcoRI and 
HindIII (sites underlined in the primer sequences), and 
cloned into pBluescript KS+ (Stratagene). DNA sequencing 
data shoWs that the insert matches the expected sequence. 
The signal peptide sequence of pathogenesis-related pro 
tein 1b (PR-1b) is ampli?ed by PCR using N. tabacum cv. 
Samsun NN genomic DNA as template and oligonucleotides 
PR-1b-5‘ (CACG 
AAGCTTACCNFGGGATTTTTTCTCTTTTCAC (SEQ ID 
NO. 8), Hind III site underlined) and PR-1b-3‘ (TC 
CCGCGGGAGTTTTGGGCATGAGAAG (SEQ ID NO. 
9), SacII site) as primers (Cornelissen et al., 1986). The 
ampli?ed sequence is cloned into pBluescript SK+. The 
cloned PR-1b signal peptide sequence is con?rmed by DNA 
sequencing. 
The hrmA gene is also ampli?ed by PCR, using 
Pseudomonas syringae pv. syringae strain 61 genomic DNA 
as template and tWo PCR primers designed according to the 
hrmA sequence (Heu and Hutcheson, 1993). TWo 5‘ primers 
are made With different restriction sites for cloning With or 
Without the PR-1b signal peptide sequence (FIG. 1) (hrmA 
5‘-1, CACGAAGCTTACCATGGACCCTATCCATGC 
(SEQ ID NO. 3), and hrmA-5‘-2,TCCG 
CCGCGGGGTGAACCCTATCCATGC (SEQ ID NO. 4), 
HindIII and SacII sites underlined). The 3‘ primer sequence 
is hrmA-3‘, GTGGAGCTCAGTTTCGCGCCCTGAG 
(SEQ ID NO. 5) (SacI site underlined). The full-length hrmA 
DNA is ?rst cloned into pBluescript KS+ and the insert is 
veri?ed by DNA sequencing. Various combinations of 
promoters, signal peptide sequences, and the hrmA gene are 
then made in the T-DNA binary vector pKYLX71: 35S2 
(Mogen et al., 1992; Maiti et al., 1993). 50 mg/l kanamycin 
is used as plant transformation selection marker. FIG. 1 
shoWs the various expression cassettes constructed. 
Tobacco Transformation and Plant GroWth Conditions 
The resulting pKYLX71: 35S2 derivatives are mobiliZed 
into Agrobacterium tumefaciens (pGV3850) and the 
transconjugants used to transform tobacco (Nicotiana 
tabacum L.) cv. KY14 as described in detail elseWhere (Li 
and Hunt 1995). Transgenic plants are groWn in a standard 
groWth chamber for a feW Weeks before moving to a 
greenhouse to produce seeds. All leaf pathogen inoculation 
experiments are carried out in a groWth chamber With 
16-hour lightness and 8-hour darkness and 22—25° C. The 
nematode inoculation tests are done in a green house. KY14 
plants transformed With the vector pKYLX71: 35S2 are used 
as control in all experiments. 
Detection of Expression of hrmA and PR Genes 
Reverse transcription folloWed by polymerase chain reac 
tion (RT-PCR) is used for hrmA transcript detection. Total 
RNA is isolated from the transgenic plants using the TRI 
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ZolTM Reagent kit (GIBCO BRL). To remove possible DNA 
contamination, the total RNA is treated With DNase then 
heated at 70° C. for 10 min to inactivate the DNase, followed 
by phenol:chloroform extraction and ethanol precipitation. 5 
g puri?ed total RNA is added to a 30 pl reverse transcription 
mixture and oligo dT is used as the ?rst strand primer. The 
resultant ?rst strand is used as PCR template and primer 
PR-1b-5‘ and hrmA-3‘ is used to amplify hrmA DNA. The 
PCR products are separated in a 1% agarose gel and blotted 
to Nytran Plus membranes (Schleicher & Schuell Inc.), and 
then probed by [ot-32P]-dCTP labeled hrmA DNA. Tobacco 
tubulin DNA is also ampli?ed from the same ?rst strand 
mixture as an internal equal loading control With oligo 
Tubulin forward (CTT GCA TTG GTA CAC AGG (SEQ ID 
NO. 10)) and Tubulin reverse (ACT TGA AAC CCA CGC 
TCC TC (SEQ ID NO. 11)) (GenBank accesion # U91564). 
To exclude that DNA may be ampli?ed from contaminant 
DNA in the RNA sample, PCR control is set up With total 
RNA samples Without reverse transcription. 
Northern blot analyses (Sambrook et al. 1989) is used for 
detection of pr gene expression. Tobacco pr-1 and pr-2 gene 
probes Were kindly provided by Dr. Yinong Yang 
(Department of Plant Pathology, University of Arkansas) 
and Dr. Santanu Dasgupta (Department of Agronomy, Uni 
versity of Kentucky), respectively, and are [ot-32P]-dCTP 
labeled using a random labeling kit (Stratagene). 20 pig of 
total RNA from each treatment are fractionated in a 1.0% 
agarose/formaldehyde gel and subsequently blotted to Nyt 
ran Plus membranes. HybridiZations are performed With the 
appropriate probes in Northern MAX Prehyb/Hyb Buffer 
(Ambion Inc.) according to the manufacturer’s instruction. 
Salicylic Acid Detection 
Salicylic acid (SA) assays are basically done as described 
(BoWling et al., 1994 and Gaffney et al., 1993). Brie?y, 0.5 
g leaf is ground in liquid N2, then methanol extracted. The 
extract is dried and the pellet resuspended in 5% TCA. After 
spin, the supernatant is partitioned With organic mixture 
(ethyl acetate:cyclopentane:isopropanol, 50:50:1). The 
organic phase is dried, and the pellet resuspended in mobile 
phase (20 mM sodium acetate, pH 5.0, 20% methanol, 250 
l) for HPLC analysis. For total SA, the TCA resuspended 
sample is heated in boiling Water bath for 30 minutes then 
extracted With the organic mixture. 20 pl of SA sample is 
injected to a C18 HPLC column and quanti?ed With Waters 
(Milford, Miss.) ?uorescence detector With the Millennium 
program. 
Pathogen Resistance Assays 
Tobacco vein mottling virus (TVMV) and tobacco etch 
virus (TEV) inocula are prepared by grinding virus-infected 
tobacco leaves in Water (1 g infected leaf tissue per 100 ml 
distilled Water). The surface of the ?fth leaf (from top of the 
plant) is dusted With carborundum and then rubbed With a 
gauZe pad moistened With a virus suspension. Five plants are 
used for each treatment. TWo Weeks later, the disease symp 
toms are scored at the top neW leaves. To further analyZe the 
presence of virus on the top leaves, tWo leaf discs (about 100 
mg) are taken from top leaf and ground in 100 pl SDS 
polyacrylamide gel electrophoresis (PAGE) loading buffer. 
20 pl of the supernatant is loaded to each gel Well. Western 
blot analysis of the viral coat proteins is described in detail 
elseWhere (Fellers et al., 1998). 
Pseudomonas syringae pv. tabaci WF4 is groWn in liquid 
Luria Bertani (LB) medium at 28° C. overnight, collected by 
centrifugation, and resuspended in 10 mM MgCl2, and 
adjusted to cell density of OD600=1.0. For bacterial groWth 
assay, the bacterial suspension is diluted 5,000 times and 
used to in?ltrate the number 5 leaf from the top. Samples of 
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inoculated tissue are taken daily by excision With a 6 mm 
cork borer. Bacteria inside the leaf discs are released by 
grinding the tissue in a microfuge tube in sterile Water and 
plated on LB medium. Bacterial population is determined 
based on the number of colonies formed in LB plates, as 
described by Bertoni and Mills (1987). The mean values 
from three plates for each of three independent inoculations 
are presented. For disease symptom observation, the 
OD600=1.0 bacterial suspension is diluted 1,000, 5,000 and 
10,000 times, then 10 pl are in?ltrated to the leaves. Disease 
symptoms are photographed at the time indicated. 
Phytophthora parasitica var. nicotianae isolate 62 (kindly 
provided by Ms. B. Kennedy, University of Kentucky) is 
groWn on an oatmeal medium (5% Gerber oatmeal and 2% 
agar, W/v) plate. After the fungal mycelia has spread 
throughout the plate (~7 days), a plug of medium containing 
the fungal mycelia is made by excision With a 6 mm cork 
borer. A piece of tobacco leaf (the 5th leaf from top) is cut 
into the siZe of a 9 cm petri dish, and placed upside doWn on 
top of a piece of Water-soaked Whatman paper. The 
mycelium-agar plugs are set on the leaf disc With the 
mycelium side contacting With the leaf surface. The dish is 
sealed and set at 28° C. With 16 hr lightness and 8 hr 
darkness. Leaves are photographed four days after inocula 
tion. 
Although the present invention has been fully described 
by Way of examples With reference to the accompanying 
draWings, it is to be noted that various changes and modi 
?cations Will be apparent to those skilled in the art. It is 
therefore intended that it is the folloWing claims, including 
all equivalents, Which are intended to de?ne the scope of this 
invention. Therefore, unless such changes and modi?cations 
depart from the scope of the present invention, they should 
be construted as being included therein. 
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SEQUENCE LISTING 
<l60> NUMBER OF SEQ ID NOS: ll 
<2 10> SEQ ID NO 1 
<2ll> LENGTH: 1128 
<2 12> TYPE: DNA 
<2 13> ORGANISM: Pseudomonas syringae 
<400> SEQUENCE: l 
gtgaacccta tccatgcacg cttctccagc gtagaagcgc tcagacattc aaacgttgat 60 
attcaggcaa tcaaatccga gggtcagttg gaagtcaacg gcaagcgtta cgagattcgt 120 
gcggccgctg acggctcaat cgcggtcctc agacccgatc aacagtccaa agcagacaag 180 
ttcttcaaag gcgcagcgca tcttattggc ggacaaagcc agcgtgccca aatagcccag 240 
gtactcaacg agaaagcggc ggcagttcca cgcctggaca gaatgttggg cagacgcttc 300 
gatctggaga agggcggaag tagcgctgtg ggcgccgcaa tcaaggctgc cgacagccga 360 
ctgacatcaa aacagacatt tgccagcttc cagcaatggg ctgaaaaagc tgaggcgctc 420 
gggcgatacc gaaatcggta tctacatgat ctacaagagg gacacgccag acacaacgcc 480 
tatgaatgcg gcagagtcaa gaacattacc tggaaacgct acaggctctc gataacaaga 540 
aaaaccttat catacgcccc gcagatccat gatgatcggg aagaggaaga gcttgatctg 600 
15 
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ggccgataca 
gaccaacgcg 
ggagcgcagt 
ggtaaagtcg 
aatggtgatc 
cctcctgaag 
tcttatgccg 
atcatggatg 
gaaagaggct 
<210> 
<2ll> 
TYPE: 
ORGAN 
Met Asn Pro 
Ser Asn Val 
Gly Lys 
35 
Val Leu 
50 
Arg 
Ala His 
65 
Ala 
Val Leu Asn 
Gly Arg Arg 
Ala Ile Lys 
115 
Phe 
130 
Ser Gln 
Asn 
145 
Arg Tyr 
Tyr Glu Cys 
Ser Ile Thr 
Glu Glu 
195 
Arg 
Ala 
210 
Asn Arg 
Pro Glu Thr 
225 
Gly Ala Gln 
Ser Val Thr 
Thr Ser 
275 
Asp 
tcgctgaaga 
cacctgagac 
tggccctcgc 
tcggtccggc 
ttgcaaaagc 
gattcgtcga 
agtcggttga 
ccttgaaagg 
atgacccgga 
SEQ ID NO 2 
LENGTH: 375 
PRT 
ISM: 
SEQUENCE: 2 
Ile His 
Asp Ile 
20 
Arg Tyr 
Pro Asp 
Leu Ile 
Glu Lys 
85 
Phe 
100 
Asp 
Ala Ala 
Gln Trp 
Leu His 
Pseudomonas 
Ala 
Gln 
Glu 
Gln 
Gly 
70 
Ala 
Leu 
Asp 
Ala 
Asp 
cagaaatgcc 
aaactcggga 
aatggcaacc 
aaaatatggc 
agtaaaactg 
acatacaccg 
agggcagcct 
ccagggcccc 
aaatccggcg 
Arg Phe 
Ala Ile 
Ile Arg 
40 
Gln 
55 
Ser 
Gly Gln 
Ala Ala 
Glu Lys 
Ser Arg 
120 
Glu 
135 
Lys 
Leu Gln 
150 
Gly Arg 
165 
Arg 
180 
Lys 
Glu Glu 
Thr Gly 
Asn Ser 
Val 
Thr 
Leu 
Phe 
Gly 
Lys Asn 
Ser Leu 
Leu 
200 
Asp 
Phe 
215 
Arg 
Arg Leu 
230 
Ala 
245 
Leu 
Gln 
260 
Gly 
Ala Ile 
Leu 
Lys 
Leu 
Ala Met 
Val Val 
Ile 
280 
Tyr 
agaaccggct 
cgacttacca 
ctgatggaca 
cagcaaactg 
ggcgaaaagc 
ctaagcatgc 
tccagccacg 
atggagaaca 
ctcagggcgc 
syringae 
Ser Ser Val 
Lys Ser Glu 
25 
Ala Ala Ala 
Lys Ala Asp 
Ser Gln Arg 
75 
Val Pro 
90 
Arg 
Gly Ser 
105 
Gly 
Leu Thr Ser 
Ala Glu Ala 
His 
155 
Glu Gly 
Ile Thr 
170 
Trp 
Tyr Ala Pro 
185 
Gly Arg Tyr 
Met Val Pro 
Thr Ile Gly 
235 
Ala Thr 
250 
Leu 
Gly Pro Ala 
265 
Asn Gly Asp 
tttttagaat 
ttggtgtaga 
agcacaaatc 
actctgccat 
tgaaaaagct 
agtcgacggg 
gacaggcgag 
gactcaaaat 
gaaactga 
Glu Ala Leu 
Gln Leu 
30 
Gly 
Asp Gly Ser 
45 
Lys Phe Phe 
60 
Ala Gln Ile 
Leu Asp Arg 
Ala Val 
110 
Ser 
Gln 
125 
Lys Thr 
Leu 
140 
Gly Arg 
Ala Arg His 
Lys Arg Tyr 
His 
190 
Gln Ile 
Ile Ala 
205 
Glu 
Lys Gln 
220 
Asp 
Val Glu Pro 
Met Asp Lys 
Lys Tyr Gly 
270 
Ala 
285 
Leu Lys 
ggttcctaaa 
acctaaatat 
tgtgacacaa 
tctttacata 
gagcggtatc 
tctcggtctt 
aacacacgtt 
ggcgctggca 
Arg His 
15 
Glu Val 
Ile Ala 
Lys Gly 
Ala Gln 
80 
Met 
95 
Leu 
Gly Ala 
Phe Ala 
Tyr Arg 
Ala 
160 
Asn 
Arg Leu 
175 
Asp Asp 
Asp Arg 
Arg Ala 
Lys Tyr 
240 
His 
255 
Lys 
Gln Gln 
Ala Val 
660 
720 
780 
840 
900 
960 
1020 
1080 
1128 
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Lys Leu Gly Glu Lys Leu Lys Lys Leu Ser Gly Ile Pro Pro Glu Gly 
290 295 300 
Phe Val Glu His Thr Pro Leu Ser Met Gln Ser Thr Gly Leu Gly Leu 
305 310 315 320 
Ser Tyr Ala Glu Ser Val Glu Gly Gln Pro Ser Ser His Gly Gln Ala 
325 330 335 
Arg Thr His Val Ile Met Asp Ala Leu Lys Gly Gln Gly Pro Met Glu 
340 345 350 
Asn Arg Leu Lys Met Ala Leu Ala Glu Arg Gly Tyr Asp Pro Glu Asn 
355 360 365 
Pro Ala Leu Arg Ala Arg Asn 
370 375 
SEQ ID NO 3 
LENGTH: 30 
TYPE: DNA 
ORGANISM: Artificial Sequence 
FEATURE: 
OTHER INFORMATION: Description of Artificial Sequence: Includes 
Promoter 
SEQUENCE: 3 
cacgaagctt accatggacc ctatccatgc 30 
SEQ ID NO 4 
LENGTH: 28 
TYPE: DNA 
ORGANISM: Artificial Sequence 
FEATURE: 
OTHER INFORMATION: Description of Artificial Sequence: Includes 
promoter 
SEQUENCE: 4 
tccgccgcgg ggtgaaccct atccatgc 28 
SEQ ID NO 5 
LENGTH: 25 
TYPE: DNA 
ORGANISM: Artificial Sequence 
FEATURE: 
OTHER INFORMATION: Description of Artificial Sequence: Includes 
promoter 
SEQUENCE: 5 
gtggagctca gtttcgcgcc ctgag 25 
SEQ ID NO 6 
LENGTH: 34 
TYPE: DNA 
ORGANISM: Artificial Sequence 
FEATURE: 
OTHER INFORMATION: Description of Artificial Sequence: Includes 
promoter 
SEQUENCE: 6 
ggaattcagc ttatctaaac aaagttttaa attc 34 
SEQ ID NO 7 
LENGTH: 37 
TYPE: DNA 
ORGANISM: Artificial Sequence 
FEATURE: 
OTHER INFORMATION: Description of Artificial Sequence: Includes 
promoter 
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<400> SEQUENCE: 7 
gtaagcttct gagcgatcct tctcactaga aaaatgc 37 
<2 10> SEQ ID NO 8 
<2ll> LENGTH: 35 
<2 12> TYPE: DNA 
<2 13> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Includes 
promoter 
<400> SEQUENCE: 8 
cacgaagctt accatgggat tttttctctt ttcac 35 
<2 10> SEQ ID NO 9 
<2ll> LENGTH: 27 
<2 12> TYPE: DNA 
<2 13> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Includes 
promoter 
<400> SEQUENCE: 9 
tcccgcggga gttttgggca tgagaag 27 
<2 10> SEQ ID NO 10 
<2ll> LENGTH: 18 
<2 12> TYPE: DNA 
<2 13> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Primers 
<400> SEQUENCE: l0 
cttgcattgg tacacagg l8 
<2 10> SEQ ID NO 11 
<2ll> LENGTH: 20 
<2 12> TYPE: DNA 
<2 13> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Primers 
<400> SEQUENCE: ll 
acttgaaacc cacgctcctc 20 
What is claimed is: 5. A method for eliciting a hypersensitive response in a 
1. An expression system comprising a A0.3TobRB7 pro- 50 
moter in operable linkage With a HrmA nucleotide having a 
sequence comprising the sequence set forth in SEQ ID 
transgenic plant, comprising: 
(a) obtaining a transgenic plant, Wherein cells of the 
N01. 
2. A plant cell transformed With the expression system transgenic Plant have been IfanSfOrIIled With the 
according to claim 1. 55 expression system according to claim 1; and 
3. A transgenic plant transformed With the expression 
system according to claim 1. (b) expressing HrmA protein in said plant, Wherein the 
4. A method for eliciting a hypersensitive response in expression of HrmA Protein from Said expression 5Y5‘ 
plant Cells, COIIIPIiSiHgI 60 tem results in a hypersensitive response in said plant. 
(a) groWing plant cells transformed With the expression 
system according to claim 1; and in to Claim 1 
(b) expressing HrmA protein in said plant cells, Wherein g ' 
the expression of HrmA protein from said expression 
6. A host cell, comprising the expression system accord 
7. A method of increasing resistance of a plant or plant 
65 _ _ 
system results in a hypersensitive response in said plant Cells to a Pathogen Selected from the group Conslstlng of 
cells. bacterial, fungal and viral pathogens, comprising: 
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(a) growing a plant or plant cells transformed With the compared to a plant or plant cells not containing said 
expression system according to claim 1; and construct; and 
(b) expressing HrrnA protein in said plant or plant cells, (ii) Wherein Said pathogen 15 Selected from the group 
(i) Wherein the eXpression of HrrnA protein from said consisting of bacterial, fungal and viral pathogens. 
expression system results in increased resistance of a 5 
plant or plant cells to a pathogen by said plant, as * * * * * 
